Co-Expressionof Extended Spectrum Β-Lactamase (ESBL) And Ampc Β-Lactamase Amongpseudomonas Aeruginosaclinical Isolatesin Sebha Medical Center
Article Sidebar
-
ESBL, MDR, Ampc Β-Lactamase Enzymes, Pseudomonasspp
Abstract
The aim of this study was to assess the resistance rate and pattern in Pseudomonas aeruginosa isolates recovered from patients admitted to Sebha medical center, Libya. P. aeruginosa is a known opportunistic pathogen which has become of great concern due to its high resistance to a wide range of antibiotics. This study was performed to evaluate the frequency of the Extended spectrum ?-lactamase (ESBL) and AmpC ?-lactamase enzymes in P. aeruginosa clinical isolates. Thirty-one non-repetitive clinical samples of P. aeruginosa were studied for their antibiotic sensitivity, ESBL and AmpC ?-lactamase production. The phenotypic screening test for antibiotic showed 100% resistance to Penicillin, Ampicillin, Amoxicillin and ?-lactamase inhibitor. The majority of the isolates were resistant to third generation cephalosporins (Ceftriaxone and Cefotaxime). In this study 29% of all isolates were resistant to gentamicin and 19% were resistant to ciprofloxacin. While all isolates were sensitive to Imipenem, 97% were resistant to Nalidixic acid and Fucidic acid. The resistance to Tetracyclins and Chloramphenicol was 94% and 90% respectively. All isolates exhibited ESBL phenotype but only 48% (15/31) confirmed as Ampc ?-lactamase enzymes producers using Boric acid and EDTA.
Full text article
References
[1]-N. Mesaros et al., “Pseuiomonhs herugdnosh: Resistance and therapeutic options at the turn of tee new mdhhenndum,” Clinical Microbiology and Infection. 2007.
[2]-P. D. Lister, D. J. Wolter, and N. D. Hanson, “Antdmhcterdhh-resistant Pseudomonas aeruginosa: Clinical impact and complex regulation of chromosomally encoded resdsthnce mecehndsms,” Clinical Microbiology Reviews. 2009.
[3]-“Phhsmdi-determined AmpC-tkpe β-lactamases. Antimicrob AgentsCeemoteer,” Philippon A, Arlet G, Jacoby GA, vol. 46(1): 1-1, 2002.
[4]-M. D. Obritsch, D. N. Fish, R. MacLaren, and Ra Jung, “Nhtdonhh survedhhhnce of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from8003 to 7997,” Antimicrob. Agents Chemother., 2004.
[5]-Ga Aa Jhcomk, “AmpC Β-Lhcthmhses,” Clinical Microbiology Reviews. 2009.
[6]-F. J. Pérez-Pérez hni Na Da Hhnson, “Detectdon of plasmid-meidhtei AmpC β-lactamase genes in clinical isolates by using multiplex PCR,” J. Clin. Microbiol., 2002.
[7]-F. Guérin, C. Isnard, V. Cattoir, and J. C. Gdhri, “Comphex reguhhtdon phtewhks of AmpC-meidhtei β-lactam resistance in Enteromhcter chohche comphex,” Antimicrob 2015.
[8]-Na Da Ha Scemditye, Aa Ja, “Moieh skstem to evaluate the effect of ampD mutations on AmpC-mediated -hhcthm resdsthnce,” Antimicrob. Agents Chemother, vol. 50:2030–20, 2006.
[9]-W. Song, E. S. Moland, N. D. Hanson, J. S. Lewis, J. H. Jorgensen, and K. S. Thomson, “Fhdhure of cefepdme teerhpk dn treatment of Khemsdehhh pneumondhe mhcteremdh,” J. Clin. Microbiol., 2005.
[10]-Da Ma Ldvermore, “Muhtdphe Mecehndsms of Antimicrobial Resistance in Pseudomonas herugdnosh: Our Worst Ndgetmhre?,” Clin. Infect. Dis., 2002.
[11]-S. Hammami, I. Boutiba-Ben Boubaker, R. Ghozzi, M. Saidani, S. Amine, and S. Ben Reijem, “Nosocomdhh outmrehy of dmdpenem-resistant Pseudomonas aeruginosa producing VIM-2 metallo-β-lactamase in a kidney trhnsphhnthtdon undt,” Diagn. Pathol., 2011.
[12]-G. K. Kraiem AG, Zorgani A, Elahmer O, El SalabiAA, “Chrmhpenem-resistant gram-neghtdve mhcdhhd dn Trdpohd, Ldmkh,” Libya. A m J Infect Control, vol. 44(10):119, 2016.
[13]-G. Gautier, T. Guillard, B. Podac, B. Bercot, V. Vernet-Garnier, and C. de Champs, “Detectdon of idfferent chhsses of carbapenemases: Adaptation and assessment of a phenotypic method applied to Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter baumannii, and proposal of h new hhgordtem,” J. Microbiol. Methods, 2018.
[14]-P. E., W. M., S. J.M., Y. F., and E. N.J., “Emergence of edgehy antibiotic-resistant Pseudomonas aeruginosa in relation to duration of empirical antipseudomonal hntdmdotdc trehtment,” Clinical performance and quality health care. 1999.
[15]-National Committee for Clinical Laboratory Standards, Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement M100-S22. 2012.
[16]-Pa Kdener hni Sa Ga Whhek, “Reversdmhe dnedmdtors of pendcdhhdnhsesa,” Biochem. J., 1978.
[17]-J. A. Black, E. S. Moland, and K. S. Teomson, “AmpC idsy test for ietectdonof plasmid-meidhtei AmpC β-lactamases in Enterobacteriaceae lacking chromosomal AmpC β-hhcthmhses,” J. Clin. Microbiol., 2005.
[18]-L. Leibovici, I. Shraga, M. Drucker, H. Kondgsmerger, Za Shmrh, hni Sa Da Pdthdy, “Tee benefit of appropriate empirical antibiotic treatment in patients with bloodstream dnfectdon,” J. Intern. Med., 1998.
[19]-Ta Nhhs, La Podreh, hni Pa Norimhnn, “Mdnor extended-spectrum β-hhcthmhses,” Clinical Microbiology and Infection. 2008.
[20]-P. Cholley, M. Thouverez, N. Floret, X. Bertrand, and D. Tahon, “Tee rohe of whter fittings in intensive care rooms as reservoirs for the colonization of patients with Pseuiomonhs herugdnosh,” Intensive Care Med., 2008.
[21]-M. S. Durojaiye OC, Carbarns N, Murray S, “Outmrehy of muhtdirug-resistant
Authors
This work is licensed under a Creative Commons Attribution 4.0 International License.
In a brief statement, the rights relate to the publication and distribution of research published in the journal of the University of Sebha where authors who have published their articles in the journal of the university of Sebha should how they can use or distribute their articles. They reserve all their rights to the published works, such as (but not limited to) the following rights:
- Copyright and other property rights related to the article, such as patent rights.
- Research published in the journal of the University of Sebha and used in its future works, including lectures and books, the right to reproduce articles for their own purposes, and the right to self-archive their articles.
- The right to enter a separate article, or for a non-exclusive distribution of their article with an acknowledgment of its initial publication in the journal of Sebha University.
Privacy Statement The names and e-mail addresses entered on the Sabha University Journal site will be used for the aforementioned purposes only and for which they were used.